HMOX1 and lung cancer: Nrf2 was shown to suppress the Fbxo22-mediated degradation of Bach1 in a heme oxygenase-1 dependent manner, suggesting that inhibition of heme oxygenase-1 could be an effective therapeutic strategy for preventing lung cancer metastasis (55).